ym 09151-2 has been researched along with mazindol in 8 studies
| Studies (ym 09151-2) | Trials (ym 09151-2) | Recent Studies (post-2010) (ym 09151-2) | Studies (mazindol) | Trials (mazindol) | Recent Studies (post-2010) (mazindol) |
|---|---|---|---|---|---|
| 249 | 6 | 13 | 631 | 73 | 31 |
| Protein | Taxonomy | ym 09151-2 (IC50) | mazindol (IC50) |
|---|---|---|---|
| Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 0.0029 | |
| Sodium-dependent dopamine transporter | Rattus norvegicus (Norway rat) | 0.0454 | |
| Sodium-dependent serotonin transporter | Homo sapiens (human) | 0.074 | |
| Sodium-dependent serotonin transporter | Rattus norvegicus (Norway rat) | 0.231 | |
| Sodium-dependent dopamine transporter | Homo sapiens (human) | 0.0275 | |
| Sodium-dependent dopamine transporter | Mus musculus (house mouse) | 0.013 | |
| Sigma non-opioid intracellular receptor 1 | Homo sapiens (human) | 0.2344 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (62.50) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boja, JW; Carroll, FI; Kuhar, MJ; Lewin, AH; Philip, A; Rahman, MA | 1 |
| Arregui, A; Hollingsworth, Z; Penney, JB; Young, AB | 1 |
| Araki, T; Fujiwara, T; Itoyama, Y; Kato, H; Kogure, K; Shuto, K | 1 |
| Araki, T; Fujiwara, T; Itoyama, Y; Kato, H; Shuto, K | 1 |
| Araki, T; Itoyama, Y; Kato, H; Tanji, H | 1 |
| Augood, SJ; Emson, PC; Hollingsworth, ZR; Penney, JB; Standaert, DG | 1 |
| Albers, DS; Augood, SJ; Breakefield, XO; Hollingsworth, Z; Leung, J; Standaert, DG; Yang, L | 1 |
| Charlton, CG; Chen, H; Lamango, NS; Lee, ES; Shepherd, KR; Soliman, KF | 1 |
8 other study(ies) available for ym 09151-2 and mazindol
| Article | Year |
|---|---|
Isothiocyanate derivatives of cocaine: irreversible inhibition of ligand binding at the dopamine transporter.
Topics: Animals; Benzamides; Binding, Competitive; Brain Stem; Carrier Proteins; Cerebral Cortex; Cocaine; Corpus Striatum; Dopamine; Dopamine Plasma Membrane Transport Proteins; In Vitro Techniques; Ligands; Male; Mazindol; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Paroxetine; Phencyclidine; Piperidines; Rats; Rats, Inbred Strains; Thiocyanates | 1991 |
Autoradiographic evidence for increased dopamine uptake sites in striatum of hypoxic mice.
Topics: Animals; Autoradiography; Benzamides; Benzazepines; Binding Sites; Corpus Striatum; Desipramine; Dopamine; Dopamine D2 Receptor Antagonists; Hypoxia; Male; Mazindol; Mice; Mice, Inbred BALB C; Receptors, Dopamine D1; Receptors, Dopamine D2; Time Factors | 1994 |
Effects of cerebral ischemia on dopamine receptors in the gerbil striatum.
Topics: Animals; Benzamides; Benzazepines; Brain Ischemia; Cerebral Cortex; Corpus Striatum; Dopamine Antagonists; Dopamine Uptake Inhibitors; Gerbillinae; Male; Mazindol; Receptors, Dopamine D1; Receptors, Dopamine D2; Spiperone | 1996 |
Effect of aging on dopaminergic receptors and uptake sites in the rat brain studied by receptor autoradiography.
Topics: Aging; Animals; Autoradiography; Benzamides; Benzazepines; Brain Chemistry; Dopamine Antagonists; Dopamine Uptake Inhibitors; Male; Mazindol; Rats; Rats, Inbred F344; Receptors, Dopamine D1; Receptors, Dopamine D2; Spiperone; Tritium | 1997 |
Sequential changes of dopaminergic receptors in the rat brain after 6-hydroxydopamine lesions of the medial forebrain bundle.
Topics: Adrenergic Agents; Animals; Autoradiography; Benzamides; Benzazepines; Brain Diseases; Dopamine; Dopamine Antagonists; Dopamine Uptake Inhibitors; Male; Mazindol; Medial Forebrain Bundle; Oxidopamine; Rats; Rats, Wistar; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Time Factors | 1998 |
Localization of dopaminergic markers in the human subthalamic nucleus.
Topics: Benzamides; Benzazepines; Biomarkers; Dopamine; Dopamine Antagonists; Dopamine Uptake Inhibitors; Humans; Mazindol; Parkinson Disease; Receptors, Dopamine D1; Receptors, Dopamine D2; RNA, Messenger; Subthalamic Nucleus; Tyrosine 3-Monooxygenase | 2000 |
Dopamine transmission in DYT1 dystonia.
Topics: 3,4-Dihydroxyphenylacetic Acid; Autoradiography; Basal Ganglia; Benzamides; Benzazepines; Binding Sites; Carrier Proteins; Dopamine; Dopamine Antagonists; Dopamine Uptake Inhibitors; Dystonia; Family Health; Homovanillic Acid; Humans; Mazindol; Membrane Glycoproteins; Membrane Transport Proteins; Molecular Chaperones; Neuropeptides; Synaptic Transmission; Tetrabenazine; Tritium; Vesicular Biogenic Amine Transport Proteins | 2004 |
The inhibitory role of methylation on the binding characteristics of dopamine receptors and transporter.
Topics: Analysis of Variance; Animals; Benzamides; Benzazepines; Binding, Competitive; Brain; Brain Chemistry; Dizocilpine Maleate; Dopamine Antagonists; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Injections, Intraventricular; Male; Mazindol; Membrane Glycoproteins; Membrane Transport Proteins; Methylation; Nerve Tissue Proteins; Protein Binding; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; S-Adenosylmethionine; Tissue Distribution; Tritium | 2004 |